PTSD affects about 6% of Americans at some point in their lives, yet standard treatments help fewer than half of patients achieve full remission. Recent research shows ketamine can rapidly reduce PTSD symptoms, often within 24 hours of treatment, by affecting brain circuits involved in fear memory and trauma processing (Feder et al., 2021).
Why PTSD Is So Difficult to Treat
Post-traumatic stress disorder fundamentally alters how your brain processes threat, memory, and safety. The amygdala—the brain region responsible for detecting danger and triggering fear responses—becomes overactive, constantly scanning for danger even when you’re safe. Meanwhile, the prefrontal cortex, the thinking and planning part of your brain that normally regulates emotional responses, loses some of its calming influence over the amygdala.
Traumatic memories get stored differently than regular memories, missing the normal sense of time and context. This is why PTSD flashbacks feel so present—your brain is reliving the trauma rather than remembering it.
Traditional treatments like prolonged exposure therapy and medications help some people, but response rates are modest. PTSD involves multiple neurotransmitter systems, which is why single-mechanism treatments may not fully address the condition’s complexity.
The Research Behind Ketamine for PTSD
The first major study demonstrating ketamine’s potential for PTSD came from Mount Sinai in 2014 (Feder et al., 2014), showing significant symptom reduction within 24 hours of a single infusion. A 2021 follow-up by the same research team tested repeated infusions—six over two weeks—and found PTSD symptoms dropped significantly, with improvements lasting almost four weeks after treatment (Feder et al., 2021).
A 2024 systematic review analyzing ten studies found consistent evidence of effectiveness, with benefits appearing within hours to days (da Silva et al., 2024). Imaging studies reveal that ketamine reduces amygdala activity while strengthening connections between emotional and thinking centers of the brain, potentially explaining why benefits last beyond the medication’s immediate effects.
Ketamine Combined With Therapy
Some of the most promising research combines ketamine with trauma-focused therapy. Several studies have paired ketamine with prolonged exposure therapy. In this approach, patients receive a ketamine infusion 24 hours before their therapy session. The idea is that ketamine’s effects on neuroplasticity—your brain’s ability to form new connections and change existing patterns—make it easier to engage with difficult trauma material and establish new, less frightening associations.
Early results from veterans show higher completion rates than exposure therapy alone. The ketamine appears to reduce dropout rates, one of the biggest challenges in trauma therapy.
At Mend The Mind, we offer ketamine-assisted psychotherapy that integrates therapeutic support during and immediately after ketamine administration, when patients often experience increased emotional openness. We also provide somatic psychedelic facilitation, which focuses on body-based awareness during ketamine sessions—particularly valuable since PTSD affects the body as much as the mind.
What the Treatment Looks Like
Based on research protocols, ketamine treatment for PTSD typically involves six IV infusions over two to three weeks. Each session takes about 40 minutes for the infusion, plus time for preparation and monitoring.
We use subanesthetic doses that allow you to remain conscious but deeply relaxed. Some people experience dissociation—a temporary feeling of detachment that may actually contribute to therapeutic benefits by creating distance from entrenched trauma reactions. Many patients describe the experience as providing a different perspective on their trauma—making memories feel less overwhelming and all-consuming.
After the initial infusion series, we develop a maintenance plan based on how you respond. Some people need periodic infusions every few weeks; others transition to ketamine troches for at-home maintenance; still others find that six infusions provide lasting benefit without additional treatment. Response patterns vary significantly, and we tailor ongoing care to your individual trajectory.
The financial reality of ketamine treatment is something we discuss openly. IV ketamine for psychiatric conditions typically isn’t covered by insurance since it’s an off-label use. A full treatment series can cost several thousand dollars, which we recognize is a significant investment. SPRAVATO®, the FDA-approved nasal spray form, may be covered by insurance for treatment-resistant depression. We provide transparent pricing during your consultation and can discuss payment options. For veterans, we can help you explore whether VA benefits might apply to your care.
Throughout treatment, we monitor not just PTSD symptoms but also co-occurring conditions. Depression and PTSD frequently occur together, and ketamine often helps both simultaneously. Chronic pain and PTSD also commonly overlap, particularly in veterans and first responders. Our comprehensive approach addresses the full picture of how PTSD affects you.
Who Responds Best to Ketamine for PTSD
People with chronic PTSD—symptoms lasting a year or longer—tend to be good candidates. Those who’ve tried standard treatments without adequate improvement are particularly appropriate. Veterans and first responders make up a significant portion of PTSD patients in ketamine research, and we’re committed to serving these communities in Montana.
People who can’t tolerate prolonged exposure therapy may find ketamine more manageable. The treatment doesn’t require detailed recounting of trauma during medication sessions. Your willingness to engage with the experience matters—patients who approach treatment with openness tend to report more meaningful experiences.
Safety Considerations Specific to PTSD
PTSD comes with specific safety considerations. Dissociation can be triggering for some trauma survivors, particularly if dissociation was part of your trauma experience. We discuss this thoroughly before treatment. Hypervigilance and startle responses can make the treatment environment feel threatening if not handled sensitively. We maintain a calm, predictable atmosphere.
Substance use disorders occur at higher rates in people with PTSD. If you’re using substances to manage symptoms, we need to address this before ketamine treatment. Suicide risk often accompanies PTSD—ketamine’s rapid anti-suicidal effects can be valuable, but treatment needs to be part of a comprehensive safety plan.
Beyond Symptom Reduction
What makes ketamine particularly interesting for PTSD isn’t just symptom reduction but that it may help people develop a different relationship with their trauma. Participants describe feeling less defined by traumatic experiences and more able to envision a future beyond their trauma.
Not everyone has profound revelatory experiences, and that’s okay. Even without dramatic breakthroughs, reducing PTSD symptoms improves daily functioning and quality of life.
What to Expect as a PTSD Patient
If you’re considering ketamine treatment for PTSD, we start with a thorough trauma assessment to understand how PTSD affects you now. We ask about symptom patterns, triggers, coping strategies, previous treatments, and your goals. We evaluate co-occurring conditions like depression, anxiety, and chronic pain.
Before your first session, we explain what will happen and what you might experience. After treatment, we check in immediately and in the following days, looking for symptom changes and any difficult experiences needing processing. If you’re doing concurrent therapy, your therapist can help integrate whatever emerged during sessions.
Living with PTSD is exhausting. The hypervigilance, the intrusive memories, the avoidance that shrinks your life, the feeling that you can’t trust your own nervous system—all of it takes a toll that’s hard to explain to people who haven’t experienced it. You deserve treatment that actually works, delivered by people who understand trauma and can provide both medical safety and psychological support.
If you’re dealing with PTSD that hasn’t responded adequately to other treatments, ketamine therapy might offer a new path forward. At Mend The Mind, we bring specialized training in both anesthesia and psychiatry to PTSD treatment, combining medical expertise with trauma-informed care. Call (406) 220-7639 to schedule a consultation and learn whether ketamine therapy could help you reclaim your life from PTSD.
FAQ Section
Q: How is ketamine for PTSD different from ketamine for depression? A: The underlying mechanism is similar—affecting glutamate and promoting neuroplasticity—but PTSD treatment often emphasizes the combination with therapy. The medication can make trauma processing more tolerable and effective. Treatment protocols are generally the same: six infusions over two to three weeks.
Q: Will ketamine make me forget my traumatic experiences? A: No. Ketamine doesn’t erase memories. Instead, research suggests it helps the brain update how traumatic memories are stored and processed, making them less overwhelming and emotionally intense. Many people describe feeling less “stuck” in their trauma rather than having forgotten it.
Q: Can I do ketamine treatment if I’m already in PTSD therapy? A: Yes, and we actually recommend continuing therapy during ketamine treatment. The combination often works better than either approach alone. Let your therapist know you’re considering ketamine so they can coordinate care with us.
Q: How quickly will I notice changes in my PTSD symptoms? A: Research shows many people notice some improvement within 24 hours of the first infusion, though the full effect builds over the treatment series. Changes might include reduced nightmares, less intense reactions to triggers, or feeling more present in daily life rather than constantly on guard.
Q: Does ketamine help with all types of trauma? A: Research has included PTSD from various trauma types—combat, assault, accidents, childhood abuse. Ketamine appears to work across different trauma origins, though individual responses vary. What matters more is whether your PTSD has been treatment-resistant rather than what caused it.
Conclusion
Research on ketamine for PTSD shows promising evidence of rapid symptom reduction in many patients, particularly when combined with trauma-focused therapy, offering new possibilities for people with treatment-resistant trauma symptoms. Results vary by individual, and the medication’s unique effects on brain plasticity may help update traumatic memories rather than just temporarily suppressing symptoms.
If you’re struggling with PTSD that hasn’t responded to conventional treatments, you don’t have to keep trying the same approaches hoping for different results. At Mend The Mind, we offer ketamine therapy with specialized expertise in both the medical administration of the treatment and the psychiatric complexities of trauma recovery. Contact us at (406) 220-7639 to schedule a consultation and explore whether ketamine could be part of your path to healing from PTSD.
References
da Silva, F. C., Pereira, V. S., Rosado, P., de Figueiredo, I. L., & Rodrigues, D. A. (2024). Effectiveness of ketamine for the treatment of post-traumatic stress disorder: A systematic review and meta-analysis. BMC Psychiatry, 24, 220. https://pmc.ncbi.nlm.nih.gov/articles/PMC10979792/
Feder, A., Parides, M. K., Murrough, J. W., Perez, A. M., Morgan, J. E., Saxena, S., Kirkwood, K., Aan Het Rot, M., Lapidus, K. A., Wan, L. B., Iosifescu, D., & Charney, D. S. (2014). Efficacy of intravenous ketamine for treatment of chronic posttraumatic stress disorder: A randomized clinical trial. JAMA Psychiatry, 71(6), 681-688. https://pubmed.ncbi.nlm.nih.gov/24740528/
Feder, A., Costi, S., Rutter, S. B., Collins, A. B., Govindarajulu, U., Jha, M. K., Horn, S. R., Kautz, M., Corniquel, M., Collins, K. A., Bevilacqua, L., Glasgow, A. M., Brallier, J., Pietrzak, R. H., Murrough, J. W., & Charney, D. S. (2021). A randomized controlled trial of repeated ketamine administration for chronic posttraumatic stress disorder. American Journal of Psychiatry, 178(2), 193-202. https://psychiatryonline.org/doi/10.1176/appi.ajp.2020.20050596
Seshadri, A., Uliana, D., Roache, J. D., Krystal, J. H., & Abdallah, C. G. (2022). The safety and efficacy of ketamine NMDA receptor blocker as a therapeutic intervention for PTSD review of a randomized clinical trial. Neuroscience & Biobehavioral Reviews, 136, 104625. https://www.sciencedirect.com/science/article/abs/pii/S0166432822000729